ARTA
AVEO

A.R.T. Advisors’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

A.R.T. Advisors’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-10,366
Closed -$85K – 1781
2019
Q1 		$85K Buy
+10,366
New +$107K 0.01% 1186
2018
Q3 		– Sell
-2,726
Closed -$61K – 1860
2018
Q2 		$61K Buy
+2,726
New +$64.6K ﹤0.01% 1328

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

A.R.T. Advisors's AVEO Position: Q2 2019 in Review

A.R.T. Advisors sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2019, closing a stake of 10,366 shares — an estimated $85K sold.

A.R.T. Advisors first reported a position in AVEO in Q2 2018 and held it in 2 quarters. The position peaked at $85K in Q1 2019. 73 funds tracked by Wall St. Rank hold AVEO as of Q2 2019.

  • A.R.T. Advisors reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 10,366 AVEO Pharmaceuticals, Inc. shares in Q2 2019, an estimated $85K.
  • A.R.T. Advisors first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2018 and held it in 2 quarters.
  • A.R.T. Advisors's AVEO Pharmaceuticals, Inc. position peaked at $85K in Q1 2019.
  • 73 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2019.

Based on A.R.T. Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.